{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "10836033", "DateCompleted": {"Year": "2000", "Month": "07", "Day": "19"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "26"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1523-7060", "JournalIssue": {"Volume": "1", "Issue": "11", "PubDate": {"Year": "1999", "Month": "Dec", "Day": "02"}}, "Title": "Organic letters", "ISOAbbreviation": "Org Lett"}, "ArticleTitle": "Epicalyxin F and calyxin I: two novel antiproliferative diarylheptanoids from the seeds of Alpinia blepharocalyx.", "Pagination": {"StartPage": "1733", "EndPage": "1736", "MedlinePgn": "1733-6"}, "Abstract": {"AbstractText": ["[formula: see text] Epicalyxin F (1) and calyxin I (2), two novel diarylheptanoids, were isolated from a residual fraction of an EtOH extract of Alpinia blepharocalyx. Calyxin I (2) represented a new carbon skeleton, and epicalyxin F (1) possessed potent antiproliferative activity toward HT-1080 fibrosarcoma and colon 26-L5 carcinoma with ED50 values of 1.71 and 0.89 microM, respectively."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Natural Medicine, Toyama Medical and Pharmaceutical University, Japan."}], "Identifier": [], "LastName": "Gewali", "ForeName": "M B", "Initials": "MB"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tezuka", "ForeName": "Y", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Banskota", "ForeName": "A H", "Initials": "AH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ali", "ForeName": "M S", "Initials": "MS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Saiki", "ForeName": "I", "Initials": "I"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Dong", "ForeName": "H", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kadota", "ForeName": "S", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Org Lett", "NlmUniqueID": "100890393", "ISSNLinking": "1523-7052"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Diarylheptanoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Pyrans"}, {"RegistryNumber": "0", "NameOfSubstance": "calyxin I"}, {"RegistryNumber": "0", "NameOfSubstance": "epicalyxin F"}], "MeshHeadingList": [{"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": [], "DescriptorName": "China"}, {"QualifierName": [], "DescriptorName": "Diarylheptanoids"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": ["chemistry"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Magnetic Resonance Spectroscopy"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["isolation & purification"], "DescriptorName": "Pyrans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Seeds"}, {"QualifierName": [], "DescriptorName": "Stereoisomerism"}, {"QualifierName": [], "DescriptorName": "Tumor Cells, Cultured"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2000", "Month": "6", "Day": "3", "Hour": "9", "Minute": "0"}, {"Year": "2000", "Month": "7", "Day": "25", "Hour": "11", "Minute": "0"}, {"Year": "2000", "Month": "6", "Day": "3", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10836033", "10.1021/ol990260p"]}}], "PubmedBookArticle": []}